Handbook of Stability Testing in Pharmaceutical Development
Regulations, Methodologies, and Best Practices
Huynh-Ba, Kim (Ed.)
2009, XVII, 389p. 72 illus..
Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.
You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.
After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.
This practical handbook is needed in this area to serve pharmaceutical scientists who handle responsibilities in a variety of functions relating to the drug stability, including R&D, formulation, analytical development, QA/QC, regulatory affairs and production
A COMPREHENSIVE AND PRACTICAL GUIDE TO STABILITY TESTING IN PHARMACEUTICAL DEVELOPMENT
Stability testing is required to demonstrate that a pharmaceutical product meets its acceptance criteria throughout its shelf life and to gain regulatory approval for commercialization. Assessing drug product stability and safety can be quite complicated, and stability profile can impact many functional areas, including analytical testing, formulation development, toxicology, quality, and regulatory affairs.
Handbook of Stability Testing in Pharmaceutical Development: Regulations, Methodologies, and Best Practices is the first volume to cover all aspects of stability testing in pharmaceutical development. It presents a scientific understanding of regulations and balances methodologies and best practices. Comprising 17 chapters, it provides a wealth of resources for pharmaceutical companies, educational institutions, and manufacturing laboratories to use as either a supplementary text for stability training courses or as a reference book for pharmaceutical practitioners.
Topics covered include:
Latest regulations for stability testing, including cGMP requirements, ICH guidelines, and global guidances from WHO, ASEAN, EMRO, and other regions.
Post-approval considerations and regulatory filing strategies to support a global supply chain.
Methodologies, including development of a stability-indicating method, method validation, and transfer. This book also discusses physical stability, non-chromatographic methodologies, and spectroscopic applications.
Setting specifications, monitoring impurities, and establishing shelf-life of pharmaceutical products.
Data management, including stability reports, CMC, and discussion of out-of-specification (OOS) and out-of-trend (OOT).
USP-NF testing in support of stability.
Current industry best practices on stability operation, validation, and calibration of stability chambers including considerations for photo-stability testing.
Discussion of matrixing and bracketing to support reduced stability testing.
Overview of stability programs for biologics and drug-in-devices pharmaceutical products.
This collective work was written by a group of prominent international experts, who have been directly responsible for instituting industry best practices and establishing the current stability guidelines.
Introduction.- Critical Regulatory Requirements for a Stability Program.- Understanding ICH guidelines applicable to Stability Testing.- Global Stability Practices.- Post-Approval Changes - Stability Requirements and Regulations.- Understanding and Predicting Pharmaceutical Product Shelf-Life.- Development of Stability Indicating Methods.- Method Validation and Transfer.- Overview of USP-NF Requirements for Stability Purposes.- Non-Chromatographic Methods to Support Stability Program.- Vibrational Spectroscopic Methods for Quantitative Analysis.- Impact of Solid-State Characteristics to the Physical Stability of Drug Substance and Drug Product.- Evaluation of Stability Data.- Qualification, Calibration and Maintenance of Stability Chambers.- Stability Operation Practices.- Combination Products/Drugs in Devices.- Stability Studies for Biologics.